Potvin et al: effects in stage 2 [Two-Stage / GS Designs]

posted by d_stat – Slovenia, 2021-07-19 18:26 (1432 d 14:08 ago) – Posting: # 22478
Views: 5,011

Dear Helmut,

I have a questions regarding analysis of two-stage Potvin C data, i.e. with regard to interaction stage*formulation that mentioned here:

❝ At least if you proceed to the second stage (see the last page of the methods-section of Potvin’s paper). Just checked it in one of my studies (Method C, which was accepted by the BfArM) – difference in the CI was 0.15% (with/without effects)… However, even if you find significant effects, no poolability criteria are to be applied anyhow.


Are you aware of any literature or guidance that would suggest that poolability of stages still applies even in case of significant formulation*stage interaction?

Thank you.

Regards

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
93 visitors (0 registered, 93 guests [including 53 identified bots]).
Forum time: 08:34 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5